BKYI Bio key International

Identity and Access Management Solutions Provider BIO-key to Participate in Digital Identity Panel at the Maxim Group Virtual Tech Conference, Tues. Oct. 10th at 12:30pm ET

Identity and Access Management Solutions Provider BIO-key to Participate in Digital Identity Panel at the Maxim Group Virtual Tech Conference, Tues. Oct. 10th at 12:30pm ET

NEW YORK and HOLMDEL, N.J., Oct. 06, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions will participate in the 2023 , presented by Maxim Group LLC and hosted by M-Vest October 10th-11th. BIO-key’s CEO Mike DePasquale will join the Identity Panel discussion on Tuesday, Oct. 10th from 12:30 to 1:30pm ET.

The conference and panel discussions will be hosted live on M-Vest. Visit: to sign-in or sign up to become an M-Vest member and access the event. Investors can submit questions to the moderator throughout the panel, as well as request management meetings.

The continuous evolution of technology is paving the way for innovations across all industries. In this conference Maxim will explore how emerging growth companies are leveraging new technologies to position themselves for the future. Senior analysts will facilitate engaging dialogues with CEOs and key management of companies who have their attention on technology and how it will impact and grow their business.

is a leading full-service investment bank, securities and wealth management firm headquartered in New York. Maxim provides a full array of financial services to a diverse range of corporate clients, institutional investors and high net worth individuals.

About BIO-key International, Inc. ()

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software managing millions of users. Its cloud-based PortalGuard IAM solution provides cost-effective, easy to deploy, convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading Identity-Bound Biometric (IBB) capabilities, enable large-scale Identity-as-a-Service (IDaaS) solutions, as well as customized on premises solutions.

Engage with BIO-key

Facebook – Corporate: 
LinkedIn – Corporate: 
Twitter – Corporate: 
Twitter – Investors: 
StockTwits: 
   

Investor Contacts

William Jones, David Collins

Catalyst IR

212-924-9800



EN
06/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bio key International

 PRESS RELEASE

BIO-key Reports Q1’25 Revenue of $1.6M and Improved Cash Position of $...

BIO-key Reports Q1’25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1’25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, “Our revenue rose app...

 PRESS RELEASE

BIO-key, Provider of Identity and Access Management Solutions Enhanced...

BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET HOLMDEL, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: BKYI), an innovative provider of Identity and Access Management solutions with unique Identity-Bound Biometric capabilities, will host its first quarter 2025 investor call on Friday, May 16th at 10 a.m. ET. Results will be released after market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call DetailsDate / T...

 PRESS RELEASE

BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving N...

BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance HOLMDEL, N.J. , April 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced today that on April 17, 2025, it received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely fi...

 PRESS RELEASE

BIO-key Partners with Arrow ECS Iberia to Strengthen Access to its Ide...

BIO-key Partners with Arrow ECS Iberia to Strengthen Access to its Identity and Access Management Solutions in Spain and Portugal BIO-key to be Introduced at Arrow ECS Iberia Partner Event in Lisbon April 2nd LISBON, Portugal and HOLMDEL, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software for phoneless, tokenless, passwordless, and phishing-resistant authentication experiences, today announced a strategic partnership with Arrow ECS Iberia, a leading cybersecurity and enterprise IT solut...

 PRESS RELEASE

BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Marg...

BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4’24) and year ended December 31, 2024 (2024). BIO-key’s 2023 results, which were restated and f...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch